These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 34103083)

  • 1. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
    Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J
    Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary metabolomic biomarker candidates for skeletal muscle wasting in patients with rheumatoid arthritis.
    Oliveira MS; Santo RCE; Silva JMS; Alabarse PVG; Brenol CV; Young SP; Xavier RM
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1657-1669. PubMed ID: 37243418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma metabolomic profiling as a tool to identify predictive biomarkers of methotrexate efficacy in rheumatoid arthritis.
    Medcalf MR; Bantis LE; Shi P; Bhadbhade P; Gundry RL; Mikuls TR; England BR; O'Dell JR; Funk RS
    Semin Arthritis Rheum; 2022 Oct; 56():152056. PubMed ID: 35785666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics profiling reveals potential alterations in rheumatoid arthritis with different disease activity levels.
    Chen J; Li S; Zhu J; Su W; Jian C; Zhang J; Wu J; Wang T; Zhang W; Zeng F; Chang S; Jia L; Su J; Zhao Y; Wang J; Zeng F
    Arthritis Res Ther; 2023 May; 25(1):74. PubMed ID: 37138305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis.
    Cuppen BV; Fu J; van Wietmarschen HA; Harms AC; Koval S; Marijnissen AC; Peeters JJ; Bijlsma JW; Tekstra J; van Laar JM; Hankemeier T; Lafeber FP; van der Greef J;
    PLoS One; 2016; 11(9):e0163087. PubMed ID: 27631111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
    Gonzalez-Ponce F; Gamez-Nava JI; Perez-Guerrero EE; Saldaña-Cruz AM; Vazquez-Villegas ML; Ponce-Guarneros JM; Huerta M; Trujillo X; Contreras-Haro B; Rocha-Muñoz AD; Carrillo-Escalante MO; Sanchez-Rodriguez EN; Gomez-Ramirez EE; Nava-Valdivia CA; Cardona-Muñoz EG; Gonzalez-Lopez L;
    PLoS One; 2021; 16(9):e0255854. PubMed ID: 34506500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in the synovial fluid metabolome according to disease activity of rheumatoid arthritis.
    Ahn JK; Kim J; Cheong YE; Kim KH; Cha HS
    Clin Exp Rheumatol; 2020; 38(3):500-507. PubMed ID: 31498072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
    Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
    Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies.
    Curtis JR; Brahe CH; Østergaard M; Lund Hetland M; Hambardzumyan K; Saevarsdottir S; Wang X; Flake Ii DD; Sasso EH; Huizinga TW
    Curr Med Res Opin; 2019 Sep; 35(9):1483-1493. PubMed ID: 30777458
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritis.
    Sasaki C; Hiraishi T; Oku T; Okuma K; Suzumura K; Hashimoto M; Ito H; Aramori I; Hirayama Y
    PLoS One; 2019; 14(7):e0219400. PubMed ID: 31295280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
    Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
    Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
    Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
    Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
    Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
    Front Immunol; 2018; 9():2388. PubMed ID: 30420853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase 4 as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis.
    Yu J; Hu C; Dai Z; Xu J; Zhang L; Deng H; Xu Y; Zhao L; Li M; Liu L; Zhang M; Huang J; Wu L; Chen G
    Int Immunopharmacol; 2023 Jun; 119():110203. PubMed ID: 37094543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index and 28-joint Disease Activity Index with C-reactive protein in rheumatoid arthritis patients.
    Yoshii I; Chijiwa T; Sawada N
    Int J Rheum Dis; 2018 Nov; 21(11):1955-1961. PubMed ID: 30175554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
    Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.